Virtus LifeSci Selected Fundamentals

BBC -- USA Etf  

USD 33.78  0.30  0.88%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Price to Book Analysis

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is accounting value of assets minus liabilities.
Virtus LifeSci 
MV Per Share 
BV Per Share 
1.75 times

About Price to Book

Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Compare to competition
Based on latest financial disclosure the price to book indicator of Virtus LifeSci Biotech Clinical Trls ETF is roughly 1.75 times. This is much higher than that of the BioShares family, and significantly higher than that of Sector category, The Price to Book for all etfs is over 1000% lower than the firm.

Virtus LifeSci Biotech Fundamental Drivers Relationships

Virtus LifeSci Biotech Clinical Trls ETF is second largest ETF in price to earning as compared to similar ETFs. It is rated below average in price to sales as compared to similar ETFs fabricating about  0.05  of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for Virtus LifeSci Biotech Clinical Trls ETF is roughly  20.04 

Peer Comparison

Virtus LifeSci Price to Book Comparison
  Price to Book 
      Virtus LifeSci Comparables 
Virtus LifeSci is currently under evaluation in price to book as compared to similar ETFs.

Fund Instrument Allocation for Virtus LifeSci

The fund invests 99.71% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.
      Instrument Type 

Current Virtus LifeSci financial ratios